Cardiovascular disease continues to be the leading cause of death worldwide. But advances in heart-failure therapeutics have ...

Researchers can use messenger RNA to trigger the immune system to attack tumors. By stimulating cancer cells to produce a ...

By stimulating cancer cells to produce a molecule that activates a signaling pathway in nearby immune cells, MIT researchers ...

The decades-long quest to harness the power of messenger RNA to enhance cancer treatment has focused primarily on its value ...

According to SNS Insider's forecast, the global Antisense and RNAi Therapeutics market will grow from USD 4.15 billion in 2023 to USD 18.48 billion by 2032, at a compound annual growth rate (CAGR) of ...

Steven Hatfill, a senior biosecurity adviser at the Department of Health and Human Services (HHS), was dismissed after ...

A commonly used strategy in the development of messenger RNA (mRNA) medicine is based on the destruction of disease-causing mRNA. Achieving the opposite and stabilizing health-promoting mRNA is still ...

A biotech stock with strong FDA approval odds this November may see limited upside amid a full valuation and a pending lawsuit.

Ribonucleic acid (RNA) is one of life's most versatile molecules, with roles going far beyond being a messenger of genetic ...

The nearly 17 million Americans who received the one-shot Johnson & Johnson coronavirus vaccine are less protected against serious illness and hospitalizations than those who got the Pfizer-BioNTech ...

Messenger RNA carries genetic information from DNA in the highly protected nucleus out to the rest of the cell, where structures called ribosomes can build proteins according to the DNA blueprint.

At the time of writing Kristie Bloom does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed the following ...